Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-21-029413
Filing Date
2021-11-19
Accepted
2021-11-19 17:14:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 323726
2 form424b5_01.jpg GRAPHIC 112812
  Complete submission text file 0001493152-21-029413.txt   480507
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256850 | Film No.: 211429289
SIC: 2834 Pharmaceutical Preparations